Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present BioSig Technologies, Inc. (OTC: BSGM).

Full DD Report for BSGM

Recent News from (OTC: BSGM)

Daily Insider Ratings Round Up 4/12/18: CONN, OPK, BSGM
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
Source: SeekingAlpha
Date: April, 14 2018 14:08
BioSig Technologies to Present at the MicroCap Conference
Santa Monica, CA, April 06, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplac...
Source: GlobeNewswire
Date: April, 06 2018 08:00
BioSig Technologies Issues 2018 Shareholder Letter
Santa Monica, CA, April 05, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( BSGM ) a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announc...
Source: GlobeNewswire
Date: April, 05 2018 08:00
BioSig Technologies, Inc. (BSGM) to Participate in Bates College's Purposeful Work Internship Program in 2018
Kenneth L. Londoner, chairman and CEO of BSGM, said in a news release that interns will be offered a ‘360-degree overview’ of the business within an entrepreneurial environment Firm is a development stage medical device company with products that assist electrophysiologists;...
Source: NetworkNewsWire
Date: March, 28 2018 09:30
BioSig Announces Submission of FDA 510(k) Application for PURE EP System
Santa Monica, CA, March 28, 2018 (GLOBE NEWSWIRE) --  BioSig Technologies, Inc. (OTCQB: BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA) for its first product, PURE EP(TM) System.  PURE EP System...
Source: GlobeNewswire
Date: March, 28 2018 08:00
BioSig Announces Submission of FDA 510(k) Application for PURE EP(TM) System
SANTA MONICA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA) for its first product, PURE EP(TM) System. PURE EP System is a surface electrocard...
Source: Thomson Reuters ONE
Date: March, 28 2018 02:00
BioSig Technologies Announces Participation in Bates College's Purposeful Work Initiative
Santa Monica, CA, March 21, 2018 (GLOBE NEWSWIRE) --  BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiolo...
Source: GlobeNewswire
Date: March, 21 2018 08:00
Business and Medical Leaders Join BioSig Advisory Board
Santa Monica, CA, March 20, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) ma...
Source: GlobeNewswire
Date: March, 20 2018 08:00
BioSig Technologies to Partner with Focus Marketing
Santa Monica, CA, Feb. 22, 2018 (GLOBE NEWSWIRE) --  BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiolog...
Source: GlobeNewswire
Date: February, 22 2018 08:00
BioSig Technologies to Open Operations Center in Austin, Texas
Santa Monica, CA, Feb. 13, 2018 (GLOBE NEWSWIRE) --  BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysio...
Source: GlobeNewswire
Date: February, 13 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-04-231.88991.901.911.8092,043
2018-04-221.88991.901.911.8092,043
2018-04-211.88991.901.911.8092,043
2018-04-201.88991.901.911.8092,043
2018-04-191.831.881.921.80106,515

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-04-2023,98592,04326.0585Cover
2018-04-1955,354105,81552.3121Short
2018-04-1817,84544,73639.8896Short
2018-04-1751,37188,02758.3582Short
2018-04-1632,42564,14450.5503Short

* Short Mode

Short Analysis provided by Squeeze Report.


About BioSig Technologies, Inc. (OTC: BSGM)

Logo for BioSig Technologies, Inc. (OTC: BSGM)

BioSig Technologies is a medical device company developing a proprietary technology platform designed to improve the . billion electrophysiology EP marketplace www.biosigtech.com . Led by a proven management team and a veteran, independent Board of Directors, Minneapolis based BioSig Technologies is preparing to commercialize its PURE EP TM System. The technology has been developed to address an unmet need in a large and growing market. The PURE EP System is a novel cardiac signal acquisition and display system which is engineered to assist electrophysiologists in clinical decision making during procedures to diagnose and treat patients with abnormal heart rates and rhythms. BioSig s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. BioSig has partnered with Minnetronix on technology development and is working toward FDA k clearance for the PURE EP System.

 

Contact Information

 

 

Current Management

  • Kenneth L Londoner / CEO
  • Steve Chaussy / CFO
  • Kenneth L Londoner / Chairman
  • Andrew Filler /
  • Seth H. Z. Fischer / Independent Director, Compensation Committee Member
  • Donald E. Foley / Independent Director, Nominating Committee Member
  • Patrick J. Gallagher / Independent Director, Audit Committee Member
  • David Weild IV / Independent Director, Audit Committee Member
  • Jeffrey F. O Donnell, Sr. / Independent Director, Audit Committee Member, Compensation Committee Member
  • Roy T Tanaka / Independent Director, Compensation Committee Member, Nominating Committee Member

Current Share Structure

  • Market Cap: $42,294,837 - 03/15/2018
  • Authorized: 200,000,000 - 10/11/2017
  • Issue and Outstanding: 29,998,466 - 02/27/2018
  • Float: 17,790,755 - 10/11/2017

 


Recent Filings from (OTC: BSGM)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 04 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: March, 26 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: March, 26 2018
Amendment to general form for registration of securities under the Securities Act of 1933
Filing Type: S-1/AFiling Source: edgar
Filing Date: March, 22 2018
General form for registration of securities under the Securities Act of 1933
Filing Type: S-1Filing Source: edgar
Filing Date: February, 28 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 27 2018
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act
Filing Type: DFiling Source: edgar
Filing Date: February, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 16 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: January, 23 2018
Post-effective amendment to an S-Type filing
Filing Type: POS AMFiling Source: edgar
Filing Date: January, 18 2018

 

 


Daily Technical Chart for (OTC: BSGM)

Daily Technical Chart for (OTC: BSGM)


Stay tuned for daily updates and more on (OTC: BSGM)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BSGM)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BSGM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of BSGM and does not buy, sell, or trade any shares of BSGM. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/

 

 

Release this Report to Investors

Via Email

Via Text

Important

If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us